3R Pharma Consulting | reducing regularity risk
Skip navigation
  • Regulatory Affairs
  • Strategy
  • Quality
    • CMC
    • Stability
    • GMP Audits
  • Clinical
  • Training
  • Team
  • Contact
    • Terms
    • Data Privacy policy
 
Contact | Links | Terms | Data Privacy Policy

FURTHER INFORMATION

EUROPE

European Medicines Agency (EMA)
EudraLex - The Rules Governing Medicinal Products in the European Union
European Directorate for the Quality of Medicines & HealthCare (EDQM)
European Pharmacopoeia (Ph. Eur.)
European Federation of Pharmaceutical Industries and Associations (EFPIA)

USA

US Food and Drug Administration (FDA)
Code of Federal Regulations (CFR)
US Pharmacopeia (USP)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Biotechnology Innovation Organization (BIO)

CANADA

Health Canada

JAPAN

Ministry of Health, Labour and Welfare (MHLW Japan)
Japan Pharmaceutical Manufacturers Association (JPMA)

AUSTRALIA

Therapeutic Goods Administration (TGA Australia)

INTERNATIONAL

World Health Organization (WHO) - Expert Committee on Specifications for Pharmaceutical Preparations
International Council for Harmonisation (ICH)
International Clinical Trials Registry Platform (ICTRP)
International Nonproprietary Names (INN)
Anatomical Therapeutic Chemical classification system and Defined Daily Dose (ATC/DDD)
International Classification of Diseases (ICD)
Orphanet - The portal for rare diseases and orphan drugs
© 2008 - 2023    3R Pharma Consulting - reducing regulatory risk
Home | Sitemap | Terms | Data Privacy Policy